Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 2 | $178,661 |
| Sells | 57 | $10,620,871 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 26 Mar 2025 16:47 | TARS | Tarsus Pharmaceuticals Inc | AZAMIAN BOBAK R. | President/CEO and Board Chair | 24 Mar 2025 | Sale | 6,000 | 50 | 300,000 | I |
| 20 Mar 2025 21:49 | TARS | Tarsus Pharmaceuticals Inc | MOTTIWALA AZIZ | Chief Commercial Officer | 18 Mar 2025 | Sale | 3,643 | 46.29 | 168,634 | D |
| 20 Mar 2025 21:49 | TARS | Tarsus Pharmaceuticals Inc | MOTTIWALA AZIZ | Chief Commercial Officer | 19 Mar 2025 | Sale | 3,557 | 47.4 | 168,602 | D |
| 20 Mar 2025 21:49 | TARS | Tarsus Pharmaceuticals Inc | MOTTIWALA AZIZ | Chief Commercial Officer | 20 Mar 2025 | Sale | 3,365 | 50.11 | 168,620 | D |
| 20 Mar 2025 21:49 | TARS | Tarsus Pharmaceuticals Inc | NEERVANNAN SESHADRI | Chief Operating Officer | 18 Mar 2025 | Sale | 2,605 | 46.29 | 120,585 | D |
| 20 Mar 2025 21:49 | TARS | Tarsus Pharmaceuticals Inc | NEERVANNAN SESHADRI | Chief Operating Officer | 19 Mar 2025 | Sale | 2,543 | 47.4 | 120,538 | D |
| 20 Mar 2025 21:49 | TARS | Tarsus Pharmaceuticals Inc | NEERVANNAN SESHADRI | Chief Operating Officer | 20 Mar 2025 | Sale | 2,435 | 50.11 | 122,018 | D |
| 20 Mar 2025 21:49 | TARS | Tarsus Pharmaceuticals Inc | WAHL BRYAN | General Counsel | 18 Mar 2025 | Sale | 3,341 | 46.29 | 154,655 | D |
| 20 Mar 2025 21:49 | TARS | Tarsus Pharmaceuticals Inc | WAHL BRYAN | General Counsel | 19 Mar 2025 | Sale | 3,261 | 47.4 | 154,571 | D |
| 20 Mar 2025 21:49 | TARS | Tarsus Pharmaceuticals Inc | WAHL BRYAN | General Counsel | 20 Mar 2025 | Sale | 3,084 | 50.11 | 154,539 | D |
| 20 Mar 2025 21:48 | TARS | Tarsus Pharmaceuticals Inc | WHITFIELD DIANNE C. | Chief Human Resources Officer | 18 Mar 2025 | Sale | 2,315 | 46.29 | 107,161 | D |
| 20 Mar 2025 21:48 | TARS | Tarsus Pharmaceuticals Inc | WHITFIELD DIANNE C. | Chief Human Resources Officer | 19 Mar 2025 | Sale | 2,259 | 47.4 | 107,077 | D |
| 20 Mar 2025 21:48 | TARS | Tarsus Pharmaceuticals Inc | WHITFIELD DIANNE C. | Chief Human Resources Officer | 20 Mar 2025 | Sale | 2,137 | 50.11 | 107,085 | D |
| 20 Mar 2025 21:48 | TARS | Tarsus Pharmaceuticals Inc | AZAMIAN BOBAK R. | President/CEO and Board Chair | 18 Mar 2025 | Sale | 7,131 | 46.29 | 330,094 | D |
| 20 Mar 2025 21:48 | TARS | Tarsus Pharmaceuticals Inc | AZAMIAN BOBAK R. | President/CEO and Board Chair | 19 Mar 2025 | Sale | 8,551 | 47.4 | 405,317 | D |
| 20 Mar 2025 21:48 | TARS | Tarsus Pharmaceuticals Inc | AZAMIAN BOBAK R. | President/CEO and Board Chair | 20 Mar 2025 | Sale | 8,534 | 50.11 | 427,639 | D |
| 20 Mar 2025 21:48 | TARS | Tarsus Pharmaceuticals Inc | FARROW JEFFREY S | See Remarks | 18 Mar 2025 | Sale | 1,284 | 46.29 | 59,436 | D |
| 20 Mar 2025 21:48 | TARS | Tarsus Pharmaceuticals Inc | FARROW JEFFREY S | See Remarks | 19 Mar 2025 | Sale | 1,254 | 47.4 | 59,440 | D |
| 20 Mar 2025 21:48 | TARS | Tarsus Pharmaceuticals Inc | FARROW JEFFREY S | See Remarks | 20 Mar 2025 | Sale | 1,186 | 50.11 | 59,430 | D |
| 14 Aug 2024 16:34 | TARS | Tarsus Pharmaceuticals Inc | LINK WILLIAM J PHD | Director | 12 Aug 2024 | Sale | 5,021 | 26.53 | 133,207 | I |
| 14 Aug 2024 16:34 | TARS | Tarsus Pharmaceuticals Inc | LINK WILLIAM J PHD | Director | 12 Aug 2024 | Sale | 29,979 | 26.01 | 779,754 | I |
| 20 Jun 2024 16:26 | TARS | Tarsus Pharmaceuticals Inc | FARROW JEFFREY S | See Remarks | 18 Jun 2024 | Sale | 10,445 | 27.47 | 286,924 | D |
| 19 Mar 2024 19:08 | TARS | Tarsus Pharmaceuticals Inc | MOTTIWALA AZIZ | Chief Commercial Officer | 18 Mar 2024 | Sale | 4,766 | 30.6 | 145,840 | D |
| 19 Mar 2024 19:05 | TARS | Tarsus Pharmaceuticals Inc | WAHL BRYAN | General Counsel | 18 Mar 2024 | Sale | 4,436 | 30.6 | 135,742 | D |
| 19 Mar 2024 19:05 | TARS | Tarsus Pharmaceuticals Inc | AZAMIAN BOBAK R. | President/CEO and Board Chair | 18 Mar 2024 | Sale | 10,415 | 30.6 | 318,699 | D |
| 19 Mar 2024 19:04 | TARS | Tarsus Pharmaceuticals Inc | WHITFIELD DIANNE C. | Chief Human Resources Officer | 18 Mar 2024 | Sale | 4,314 | 30.6 | 132,008 | D |
| 19 Mar 2024 19:03 | TARS | Tarsus Pharmaceuticals Inc | NEERVANNAN SESHADRI | Chief Operating Officer | 18 Mar 2024 | Sale | 4,879 | 30.6 | 149,297 | D |
| 29 Dec 2023 17:08 | TARS | Tarsus Pharmaceuticals Inc | AZAMIAN BOBAK R. | President/CEO and Board Chair | 27 Dec 2023 | Sale | 8,000 | 20.22 | 161,760 | I |
| 22 Dec 2023 17:32 | TARS | Tarsus Pharmaceuticals Inc | TREVEJO JOSE M. | CHIEF MEDICAL OFFICER | 20 Dec 2023 | Sale | 2,252 | 20 | 45,040 | D |
| 22 Dec 2023 17:30 | TARS | Tarsus Pharmaceuticals Inc | AZAMIAN BOBAK R. | President/CEO and Board Chair | 20 Dec 2023 | Sale | 30,557 | 20.36 | 622,141 | I |
| 22 Dec 2023 17:30 | TARS | Tarsus Pharmaceuticals Inc | AZAMIAN BOBAK R. | President/CEO and Board Chair | 20 Dec 2023 | Sale | 9,443 | 19.96 | 188,482 | I |
| 19 Dec 2023 18:30 | TARS | Tarsus Pharmaceuticals Inc | GOLDBERG ANDREW D. | Director | 15 Dec 2023 | Purchase | 1,000 | 18.96 | 18,960 | D |
| 01 Dec 2023 16:58 | TARS | Tarsus Pharmaceuticals Inc | WHITFIELD DIANNE C. | Chief Human Resources Officer | 30 Nov 2023 | Sale | 8,355 | 16.31 | 136,270 | D |
| 01 Dec 2023 16:55 | TARS | Tarsus Pharmaceuticals Inc | WAHL BRYAN | General Counsel | 30 Nov 2023 | Sale | 8,356 | 16.31 | 136,286 | D |
| 17 Nov 2023 16:50 | TARS | Tarsus Pharmaceuticals Inc | AZAMIAN BOBAK R. | President/CEO and Board Chair | 15 Nov 2023 | Sale | 200 | 19.28 | 3,856 | I |
| 17 Nov 2023 16:50 | TARS | Tarsus Pharmaceuticals Inc | AZAMIAN BOBAK R. | President/CEO and Board Chair | 15 Nov 2023 | Sale | 4,904 | 18.54 | 90,920 | I |
| 17 Nov 2023 16:50 | TARS | Tarsus Pharmaceuticals Inc | AZAMIAN BOBAK R. | President/CEO and Board Chair | 15 Nov 2023 | Sale | 2,896 | 18.01 | 52,157 | I |
| 20 Oct 2023 16:41 | TARS | Tarsus Pharmaceuticals Inc | AZAMIAN BOBAK R. | President/CEO and Board Chair | 18 Oct 2023 | Sale | 8,000 | 13.24 | 105,920 | I |
| 06 Oct 2023 17:21 | TARS | Tarsus Pharmaceuticals Inc | TREVEJO JOSE M. | CHIEF MEDICAL OFFICER | 05 Oct 2023 | Sale | 1,604 | 18 | 28,872 | D |
| 22 Sep 2023 17:30 | TARS | Tarsus Pharmaceuticals Inc | AZAMIAN BOBAK R. | President/CEO and Board Chair | 20 Sep 2023 | Sale | 8,000 | 17.21 | 137,680 | I |
| 25 Aug 2023 17:12 | TARS | Tarsus Pharmaceuticals Inc | AZAMIAN BOBAK R. | President/CEO and Board Chair | 23 Aug 2023 | Sale | 8,000 | 17.23 | 137,840 | I |
| 17 Aug 2023 18:02 | TARS | Tarsus Pharmaceuticals Inc | LIN ELIZABETH YEU | Director | 15 Aug 2023 | Purchase | 9,506 | 16.8 | 159,701 | I |
| 21 Jul 2023 17:46 | TARS | Tarsus Pharmaceuticals Inc | MOTTIWALA AZIZ | Chief Commercial Officer | 19 Jul 2023 | Sale | 2,400 | 20.05 | 48,120 | D |
| 21 Jul 2023 17:42 | TARS | Tarsus Pharmaceuticals Inc | AZAMIAN BOBAK R. | President/CEO and Board Chair | 19 Jul 2023 | Sale | 99,726 | 20.04 | 1,998,509 | I |
| 21 Jul 2023 17:42 | TARS | Tarsus Pharmaceuticals Inc | AZAMIAN BOBAK R. | President/CEO and Board Chair | 19 Jul 2023 | Sale | 4,174 | 19.28 | 80,475 | I |
| 14 Jul 2023 16:40 | TARS | Tarsus Pharmaceuticals Inc | AZAMIAN BOBAK R. | President/CEO and Board Chair | 12 Jul 2023 | Sale | 9,000 | 17.35 | 156,150 | I |
| 23 Jun 2023 16:29 | TARS | Tarsus Pharmaceuticals Inc | AZAMIAN BOBAK R. | President/CEO and Board Chair | 21 Jun 2023 | Sale | 8,000 | 18.63 | 149,040 | I |
| 16 Jun 2023 16:48 | TARS | Tarsus Pharmaceuticals Inc | AZAMIAN BOBAK R. | President/CEO and Board Chair | 14 Jun 2023 | Sale | 9,000 | 18.58 | 167,220 | I |
| 12 Jun 2023 17:40 | TARS | Tarsus Pharmaceuticals Inc | AZAMIAN BOBAK R. | President/CEO and Board Chair | 08 Jun 2023 | Sale | 3,100 | 20.01 | 62,031 | I |
| 12 Jun 2023 17:25 | TARS | Tarsus Pharmaceuticals Inc | MOTTIWALA AZIZ | Chief Commercial Officer | 08 Jun 2023 | Sale | 100 | 20 | 2,000 | D |
| 08 Jun 2023 19:16 | TARS | Tarsus Pharmaceuticals Inc | MOTTIWALA AZIZ | Chief Commercial Officer | 07 Jun 2023 | Sale | 2,500 | 19.34 | 48,350 | D |
| 08 Jun 2023 19:16 | TARS | Tarsus Pharmaceuticals Inc | MOTTIWALA AZIZ | Chief Commercial Officer | 06 Jun 2023 | Sale | 2,143 | 18.61 | 39,881 | D |
| 19 May 2023 19:08 | TARS | Tarsus Pharmaceuticals Inc | AZAMIAN BOBAK R. | President/CEO and Board Chair | 17 May 2023 | Sale | 8,000 | 15.9 | 127,200 | I |
| 12 May 2023 17:08 | TARS | Tarsus Pharmaceuticals Inc | AZAMIAN BOBAK R. | President/CEO and Board Chair | 10 May 2023 | Sale | 9,000 | 16.8 | 151,200 | I |
| 02 May 2023 19:06 | TARS | Tarsus Pharmaceuticals Inc | AZAMIAN BOBAK R. | President/CEO and Board Chair | 01 May 2023 | Sale | 5,841 | 15.1 | 88,199 | I |
| 02 May 2023 19:06 | TARS | Tarsus Pharmaceuticals Inc | AZAMIAN BOBAK R. | President/CEO and Board Chair | 28 Apr 2023 | Sale | 4,278 | 15.13 | 64,726 | I |
| 25 Apr 2023 17:22 | TARS | Tarsus Pharmaceuticals Inc | AZAMIAN BOBAK R. | President/CEO and Board Chair | 21 Apr 2023 | Sale | 2,311 | 15.03 | 34,734 | I |
| 21 Apr 2023 17:53 | TARS | Tarsus Pharmaceuticals Inc | GREENSTEIN LEONARD M. | Chief Financial Officer | 20 Apr 2023 | Sale | 5,000 | 14.02 | 70,100 | D |
| 21 Apr 2023 17:49 | TARS | Tarsus Pharmaceuticals Inc | AZAMIAN BOBAK R. | President/CEO and Board Chair | 19 Apr 2023 | Sale | 8,000 | 13.6 | 108,800 | I |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)